Ryaltris — Class II drug recall D-0006-2025
Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2024-10-09, distributed nationwide. Defective Delivery System: The dip tube is clogged causing the spray not to work.
| Recall number | D-0006-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2024-09-24 |
| Classified | 2024-10-03 |
| Reported by FDA | 2024-10-09 |
| Distributed | Nationwide (US) |
| Quantity | 45,504 bottles |
| NDC | 59467-0700, 59467-0700-27, 59467-0700-84 |
| Lot numbers | 14230425, 14240024, 14240029, 14240076, 14240082, 14240090, 14240100, DEC-25, JAN-26, NOV-25 |
Product
Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.
Reason for recall
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0006-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.